Innovative Diagnostics
- Home
- Companies
- Innovative Diagnostics
- Products
- Innovative diagnostics - DI SARS-CoV-2 ...
Innovative diagnostics - DI SARS-CoV-2 MOC/I Multiplex (CE-IVD)
In vitroDiagnostic Medical Device for the detection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ARN in humans and the screening of its mutations of concern and interest
Most popular related searches
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
sars-cov-2
real-time PCR
COVID 19
respiratory syndrome
clinical diagnostics
nasopharyngeal swab
medical device
coronavirus sars
diagnostic clinic
- CE-IVD
- Multiplex analysis: SARS-CoV-2 virus detection and screening of 8 mutations on S gene for variants identification (VOC α, β, γ, δ, ο, BA.2, BA.4/5 et VOI)
- Automated interpretation: DISoft software supplied with the kit for analysis and interpretation multiplex
- Freeze-dried format: Room temperature shipping is more economical/environmentally friendly and meets the requirements of long-distance shipping
- High specificity: primers and probes based on CDC (USA) publication
- High sensitivity: PCR limit of detection of 5 copies/µL for the SARS-CoV-2 detection and between 5 and 10 copies/µL for the screening of mutations.
- Reliability:
- Detection of an endogenous internal control to ensure the validity of the analysis
- High diagnostic sensitivity and specificity
- Thermocycler reproducibility: performance validated on QuantStudio5TM, MIC (BMS) and CFX Opus 96 Real-time PCR Instrument
Method :RT-qPCR - HRM - Multiplex - Qualitative
Species :Humans
Target gene :N1, N2 and GAPDH
Sample types :Nasopharyngeal swabs
Protocol :Duration approx. 1h15
Thermocyclers :QuantStudio 5™ (Applied Biosystems), MIC (BMS) and CFX OPUS 96 Real-Time PCR Instrument (BIO-RAD)
Shipping temperature :Room temperature
Storage temperature :-16°C; -26°C
Marking :CE-IVD
Product reference Reactions
DICOV-MOCI-100 100 tests
DICOV-MOCI-50 50 tests